Publications by authors named "S Ozkurt"

Background: The goal of this research is to investigate the clinical characteristics and prognosis of men with metastatic breast cancer (mMBC).

Methods: A retrospective analysis of the data of 28 patients was conducted. Kaplan-Meier and Cox regression analyses were used to assess overall survival (OS) and prognostic variables.

View Article and Find Full Text PDF

Background: The goal of this study was to assess the clinicopathologic characteristics and prognostic variables in men with breast cancer (BC).

Methods: Clinical features, pathological characteristics, stage at diagnosis, and therapy data were noted. Survival analysis was performed using the log-rank technique and Cox regression model.

View Article and Find Full Text PDF

Introduction Anabolic androgenic steroids (AAS) and diet supplements (DS) are frequently used by bodybuilders. In this specific group, increased muscle mass, the acute effects of exercise, and the use of creatine may affect the creatinine-based estimated glomerular filtration rate (eGFRcr), potentially leading to an underestimation of the GFR. Cystatin C equations offer a more accurate prediction of GFR that is independent of muscle mass.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on patients with HER2-positive metastatic breast cancer who are at risk for brain metastases, aiming to evaluate their prognosis and influencing factors.
  • Clinical and pathological features were analyzed for 83 patients, revealing important data such as median overall survival of 34.9 months and various factors that significantly impact prognosis, like estrogen receptor status and the size of brain metastasis.
  • Key findings suggest that larger brain metastasis size and certain treatment combinations (like TDM-1 and lapatinib with capecitabine) play critical roles in determining patient outcomes.
View Article and Find Full Text PDF

Background: Encapsulated papillary carcinoma (EPC) is a rare malignant papillary breast cancer accounting for approximately .5%-2% of all breast tumors. The aim of this multicenter study was to evaluate clinicopathologic features of EPC in addition to oncological outcomes and radiotherapy (RT) details.

View Article and Find Full Text PDF